Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Oligodendroglioma 2Glioblastoma 2Astrocytoma 2Optic Nerve Glioma 1Gliosarcoma 1Glioma 1Ependymoma 1Brain Neoplasms 1

Interventions

etoposide phosphate 3Ifosfamide 2Filgrastim 2Etoposide 2Carboplatin 2sodium thiosulfate 1sargramostim 1fluorodopa F 18 1Topotecan 1Thiotepa 1Stem Cell Transplantation 1Semaxinib 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Perfusion Magnetic Resonance Imaging 1Microarray Analysis 1Mesna 1Melphalan 1Mannitol 1Magnetic Resonance Spectroscopy 1Immunohistochemistry 1Granulocyte Colony-Stimulating Factor 1Dynamic Contrast Enhanced Magnetic Resonance Imaging 1Doxorubicin 1Dexamethasone 1Dasatinib 1Cyproheptadine 1Cyclophosphamide 1Calcium Dobesilate 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Optic Nerve Glioma × Perfusion Magnetic Resonance Imaging × Clear all
NCT02372409 2024-11-01

Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors

Washington University School of Medicine

Phase 2 Terminated
6 enrolled 10 charts
CNS

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡